First-Line Bevacizumab and Chemotherapy in Metastatic Cancer of the Colon or Rectum - International Study

Sponsor
King Faisal Specialist Hospital & Research Center
Study ID
NCT00537901
Status
Completed

Conditions

  • Colonic Neoplasms
  • Rectal Neoplasms

Eligibility Criteria

Sex
ALL
Age
N/A - N/A
Healthy Volunteers
Not accepted

Interventions

Study Details

First-Line Bevacizumab and Chemotherapy in Metastatic Cancer of the Colon or Rectum

Key Dates

First listed
Oct 2, 2007
Start date
Oct 31, 2007
Status verified
Dec 2015
Primary completion
Oct 31, 2013
Completion
Oct 31, 2013

Study Design

Enrollment
100 participants (actual)
Allocation
NON_RANDOMIZED
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT

Primary Outcome Measure

Effectiveness [ Time Frame: overall ]

Related Studies